HighPoint Advisor Group’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,646
Closed -$203K 1078
2025
Q3
$203K Sell
1,646
-211
-11% -$26.2K 0.01% 660
2025
Q2
$223K Sell
1,857
-266
-13% -$35.5K 0.01% 617
2025
Q1
$300K Buy
2,123
+150
+8% +$22.9K 0.02% 490
2024
Q4
$293K Sell
1,973
-52
-3% -$8.51K 0.02% 516
2024
Q3
$330K Buy
2,025
+5
+0.2% +$741 0.02% 460
2024
Q2
$266K Buy
2,020
+65
+3% +$9.03K 0.02% 506
2024
Q1
$276K Sell
1,955
-780
-29% -$116K 0.02% 487
2023
Q4
$412K Buy
+2,735
New +$365K 0.03% 400
2022
Q2
$471K Buy
+3,209
New +$458K 0.05% 304
2021
Q3
$412K Buy
2,485
+233
+10% +$40.1K 0.04% 342
2021
Q2
$405K Buy
2,252
+12
+0.5% +$2.19K 0.04% 340
2021
Q1
$426K Buy
2,240
+192
+9% +$37K 0.05% 308
2020
Q4
$384K Sell
2,048
-59,892
-97% -$12.4M 0.05% 308
2020
Q3
$9.44M Buy
61,940
+56
+0.1% +$12.5K 1.71% 8
2020
Q2
$10.5M Sell
61,884
-582
-0.9% -$116K 2.25% 4
2020
Q1
$11.4M Sell
62,466
-1,300
-2% -$215K 2.72% 4
2019
Q4
$13.1M Buy
63,766
+22,073
+53% +$3.3M 2.7% 5
2019
Q3
$8.18M Buy
41,693
+304
+0.7% +$48.1K 1.81% 9
2019
Q2
$8.45M Sell
41,389
-323
-0.8% -$49.3K 1.98% 8
2019
Q1
$7.38M Buy
41,712
+7,016
+20% +$1.09M 1.81% 11
2018
Q4
$6.02M Buy
34,696
+322
+0.9% +$50.2K 1.59% 11
2018
Q3
$6.18M Sell
34,374
-111
-0.3% -$15.8K 1.69% 10
2018
Q2
$5.77M Buy
34,485
+154
+0.4% +$19K 1.56% 11
2018
Q1
$5.79M Buy
34,331
+103
+0.3% +$13.8K 1.59% 11
2017
Q4
$5.43M Sell
34,228
-2,824
-8% -$384K 1.55% 12
2017
Q3
$5.18M Sell
37,052
-332
-0.9% -$44.6K 1.61% 11
2017
Q2
$4.72M Hold
37,384
1.52% 10
2017
Q1
$4.72M Sell
37,384
-5,863
-14% -$759K 1.52% 10
2016
Q4
$5.51M Buy
43,247
+1,245
+3% +$147K 1.77% 8
2016
Q3
$4.85M Sell
42,002
-4,193
-9% -$549K 1.71% 8
2016
Q2
$4.94M Buy
46,195
+39,825
+625% +$5.16M 1.73% 9
2016
Q1
$678K Sell
6,370
-234
-4% -$29.7K 0.42% 66
2015
Q4
$692K Buy
6,604
+4,726
+252% +$587K 0.46% 67
2015
Q3
$217K Buy
+1,878
New +$211K 0.24% 125

Other funds holding CLX

HighPoint Advisor Group's CLX Position: Q4 2025 in Review

HighPoint Advisor Group sold out of Clorox (CLX) in Q4 2025, closing a stake of 1,646 shares — an estimated $203K sold.

HighPoint Advisor Group first reported a position in CLX in Q3 2015 and held it in 34 quarters. The position peaked at $13.1M in Q4 2019. 1,051 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

  • HighPoint Advisor Group reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
  • HighPoint Advisor Group sold 1,646 Clorox shares in Q4 2025, an estimated $203K.
  • HighPoint Advisor Group first reported a position in Clorox in Q3 2015 and held it in 34 quarters.
  • HighPoint Advisor Group's Clorox position peaked at $13.1M in Q4 2019.
  • 1,051 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on HighPoint Advisor Group's 13F filing for Q4 2025, filed 4 Feb 2026.